Other articles

Photo by indra projects from Pexels

Sangamo Gets Lifeline From Eli Lilly In $1.4 Billion Dollar Deal For Proprietary AAV Capsid

Photo by Thirdman from Pexels

Second FDA Rejection Of Aldeyra Therapeutics But Hope Remains With Two Upcoming Events

Photo by Thirdman from Pexels

Cassava Sciences Scraps Alzheimer’s Drug Development Of Simufilam After Latest Trial Failure

Photo by cottonbro studio from Pexels

Lexicon Establishes $1 Billion Milestone Deal With Novo Nordisk To Advance Weight Loss Drug LX9851

Scroll to Top